Publications

Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression: a randomized placebo-controlled trial

 4
Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression: a randomized placebo-controlled trial

Tags:

Previous Article

Timescapes of non-human experience

Next Article

Parkinson's medication shows promise in treating depression

Related Posts

Inducing ferroptosis to impede metastasis by inhibiting the calcium channel TRPC6

Inducing ferroptosis to impede metastasis by inhibiting...

 51

Dominant clones leverage developmental epigenomic states to drive ependymoma

Dominant clones leverage developmental epigenomic state...

 46

Bilirubin metabolism in the liver orchestrates antiviral innate immunity in the body

Bilirubin metabolism in the liver orchestrates antivira...

 108